The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas

• Autorzy: Dembinski A. , Warzecha Z. , Konturek S. J. , Banas M. , Cai R.-Z. , Schally A. V.
• Języki publikacji: EN

Abstrakty

EN

The effects of gastrin, cholecystokinin (CCK) and bombesin on the DNA synthesis, as a biochemical indicator of trophic action in the gastroduodenal mucosa and the pancreas, have been examined in rats fasted for 48 h and in rats refed for 16 h with or without administration of specific receptor antagonists for bombesin, gastrin and CCK. Bombesin and gastrin administered three times daily for 48 h in fasted rats significantly increased the rate of DNA synthesis as measured by the incorporation of [³H] thymidine into DNA in each tissue tested. CCK significantly increased DNA synthesis in the duodenal mucosa and pancreatic tissue, but not in the gastric mucosa. The stimulation of DNA synthesis induced by bombesin in the gastroduodenal mucosa and pancreas was abolished by bombesin/GRP receptor antagonist, RC-3095. RC-3095 did not affect DNA synthesis stimulated by gastrin and CCK in these tissues. L-365,260, a receptor antagonist for gastrin suppressed the DNA synthesis induced by gastrin but not by CCK or bombesin in the gastrointestinal mucosa and pancreas. L-364,718, a specific antagonist for CCK receptors was effective only against CCK stimulated duodenal mucosa and pancreatic growth. Refeeding of 48 h fasting rats strongly enhanced the DNA synthesis in all tissues tested, and this effect was significantly reduced in the gastroduodenal mucosa by blocking only gastrin receptors (with L-365, 260) and that in the duodenal mucosa and the pancreas by antagonizing of CCK receptors (with L-364, 718). Antagonism of bombesin receptors (with RC-3095) did not significantly affect the stimulation of DNA synthesis induced by refeeding in all tissues tested. This study indicates that the stimulation of DNA synthesis can be achieved by exogenous gastrin, CCK and bombesin acting through separate receptors, but that only gastrin and CCK play the major role in the postprandial stimulation of the growth of gastroduodenal mucosa and pancreatic tissue.

Słowa kluczowe

EN

gastrin; cholecystokinin; bombesin; DNA synthesis; gastroduodenal mucosa; pancreas; receptor antagonist

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 1991
• Tom: 42
• Numer: 3
• Opis fizyczny: p.263-277,fig.,ref.

Twórcy

autor

Dembinski A.

• Institute of Physiology, Academy of Medicine, Grzegorzecka 16, 31-531 Krakow, Poland

autor

Warzecha Z.

• Institute of Physiology, Academy of Medicine, Grzegorzecka 16, 31-531 Krakow, Poland

autor

Konturek S. J.

• Institute of Physiology, Academy of Medicine, Grzegorzecka 16, 31-531 Krakow, Poland

autor

Banas M.

• Institute of Physiology, Academy of Medicine, Grzegorzecka 16, 31-531 Krakow, Poland

autor

Cai R.-Z.

• VA Medical Center and Department of Medicine New Orleans, USA

autor

Schally A. V.

• VA Medical Center and Department of Medicine New Orleans, USA

Bibliografia

• 1. Seidel ER. Hormonal regulation of postprandial induction of gastrointestinal ornithine decarboxylase activity. Am J Physiol 1986; 251: G460-G466.
• 2. Folsch UR. Regulation of pancreatic growth. Clin Gastroenterol 1984; 13: 679-699.
• 3. Stainer MH, Boughes HR, Freedman LS, Gray SJ. Effect of starvation on the tissue composition of the small intestine in that rat. Am J Physiol 1968; 215: 75-77.
• 4. Webster PD, Singh M, Tucker PC, Black O, et al. Effects of fasting and feeding on the pancreas. Gastroenterology 1972; 62: 600-605.
• 5. Mainz DL, Black 0, Webster PD, et al. Hormonal control of pancreatic growth. J Clin Invest 1973; 52: 2300-2304.
• 6. Johnson LR, Copeland EM, Dudrick SJ, et al. Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats. Gastroenterology 1975a; 68: 1177-1183.
• 7. Hughes CA, Prince A, Dowling RH, et al. Speed of change in pancreatic mass and in intestinal bacteriology of parenterally fed rats. Clin Sci 1980; 59: 329-336.
• 8. Levine GM, Deren J J, Steiger E, Zinno R. Role of oral intake in maintenance of gut mass and disaccharide activity. Gastroenterology 1974; 67: 975-982.
• 9. Dembinski A, Warzecha Z, Konturek SJ, Schally AV. Effect of somatostatin on the growth of gastrointestinal mucosa and pancreas in rats. Role of endogenous gastrin. Gut 1987; 28: 227-232.
• 10. Walsh J. Gastrointestinal hormones and peptides. In Physiology of the gastrointestinal tract (Ed.) Johnson LR. New York: Eaven Press, 1981: 145-168.
• 11. Johnson LR, Lichtenberger LM, Copeland EM, et al. Action of gastrin on gastrointestinal structure and function. Gastroenterology 1975b; 68: 1184-1192.
• 12. Hughes CA, Breuer RS, Dancker DA, et al. The effect of cholecystokinin and secretin on intestinal and pancreatic structure and function. In Mechanisms of IntestinalAdaptation (Ed.) Robinson JWL, Dowling RH, Riecken ED, et al. Lancater: JfTP Press 1982: 435-451.
• 13. Erspamer V, Falconieri Erspamer Gr, Inselvini M, Negri L, et al. Occurrence of bombesin and alytesin in extracts of the skin of three European discoglossid frogs and pharmacological actions of bombesin on extravascular smooth muscle. Br. J Pharmacol 1972; 45: 333-348.
• 14. Walsh JH, Wong HC, Dockray GJ, et al. Bombesin-like peptides in mammals. Fed Proc 1979, 38: 2315-2319.
• 15. Varga G, Papp M, Dobronyi I, Scarpignato D, et al. Effect of bombesin and its mammalian counter-part, GRP, on exocrine pancreas in the rat. Digestion 1988; 1988; 41: 229-236.
• 16. Lewis LD, Williams JA. Regulation of cholecystokin secretion by food, hormones, and neural pathway in the rat. Am J Physiol 1990; 255: G512-518.
• 17. Dembinski A, Konturek PK, Konturek SJ. Role of gastrin and cholecystokinin in the growth promoting action of bombesin on the gastroduodenal mucosa and the pancreas. Regulatory Peptides 1990; 27: 343-354.
• 18. Lhoste E, Abrahamian M, Pousse A, Hoeltzel A, Stock-Damge C, et al. Trophic effects of bombesin on the rat pancreas: is it mediated by the release of gastrin or cholecystokinin ? Peptides 1985; 6 : 89-97.
• 19. Johnson LR, Dudrick SJ, Guthrie PD. Stimulation of pancreatic growth by intraduodenal amino acids and HCl. Am J Physiol 1980; 239: G400-405.
• 20. Ceriotti G. Determination of nucleic acids in animal tissues. J Biol Chem 1955; 214: 59-65.
• 21. Giles KW, Myers A, et al. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 1975; 206: 93-95.
• 22. Liddle RA, Goldfine ID, Rosen MS, Taplitz R, Williams JA, et al. Cholecystokinin bioactivity in humans plasma: molecular forms, responses to feeding and relationship to gallbladder contraction. J Clin Invest 1985; 75: 1144-1152.
• 23. Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RSL, Clindeschmidt BV, et al. In vivo pharmacology of L-364, 718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Therap 1987; 241: 103-109.
• 24. Schmidt WE, Choudhury AR, Siegel EG, Loser C, Conlon IM, Folsch UR, Creutzfeldt W, et al. CCK-antagonist L-364, 718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides. Peptides 1989; 24: 67-79.
• 25. Beck MG, DiGardo RM, Evans BE, Rittle KE, Whitter WL, Veber DF, Anderson PS, Freidinger RM. Benzodiazepine gastrin and brain cholecystokinin receptor ligand, L-365, 260. J Med Chem 1989; 32: 13-16.
• 26. Dembinski AD, Johnson LR. Growth of pancreas and gastrointestinal mucosa in antrectomized and gastrin-treated rats. Endocrinology 1979; 105: 769-773.
• 27. Blom H, Erkoinen T. Trophic effect of pentagastrin on normal and regenerating parietal cells. Gastroenterology 1984; 87: 537-541.
• 28. Mayston PD, Borrowman J A. The influence of chronic administration of pentagastrin on the rat pancreas. Q J Exp Physiol 1971; 56: 113-122.
• 29. Chariot J, Lehy T, Nosca S, Dubrasquet M. Effect de Phypergastrinic prolongee sur le pancreas de rat. Biologie et Gastro-Enterologie 1974; 7: 221-236.
• 30. Johansson H, Grimelius L, Heitz PhU, et al. The effects of endogenous hypergastrinemia and hypogastrinemia on the exocrine and endocrine rat pancreas. Uppsala Journal of Medicine Science 1979; 84: 247-254.
• 31. Johnson LR. Regulation of gastrointestinal growth. In Physiology of gastrointestinal tract (Ed.) Johnson LR. New York: Raven Press. 1987: 306-307.
• 32. Folsch UR, Cantor P, Willms HM, Schafmayer A, Becker HD, Creutzfeldt W. Role of cholecystokinin in negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology 1987; 92: 449-458.
• 33. Peterson H, Solomon T, Grossman MI, et al. Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas in rats. Am J Physiol 1978; 234: E286-293.
• 34. Logsdon CD: Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am J Physiol 1986; 251: G487-494.
• 35. Johnson LR, Guthrie PD. Effect of cholecystokinin and 16, 16-dimethyl prostaglandin E₂ on RNA and DNA of gastric and duodenal mucosa. Gastroenterology 1976; 70: 59-65.
• 36. Hughes CA, Botes T, Dowling RH. Cholecystokinin and secretin prevent the intestinal mucosa hypoplasia of total parenteral nutrition in the dog. Gastroenterology 1978; 75: 34-41.
• 37. Weser E, Heller R, Tawil T. Effect of octapeptide cholecystokinin, secretin and glucagon on intestinal mucosal growth in parenterally nourished rats. Dig Dis Sci 1981; 26: 409-416.
• 38. Dembinski A, Jaworek J, Konturek SJ, Warzecha Z. Cholecystokinin receptor antagonism by peptidergic and nonpeptidergic agents in rats. J Physiol 1989; 411: 419-435.
• 39. Sjovall M, Ekblad E, Lundell L, Sundler F. Gastrin releasing peptide: neuronal distribution and spatial relation to endocrine cells in the human upper gut. Begul Peptides 1990; 28: 47-55.
• 40. Lehy T, Accory JP, Labeille D, Dubrasquet M. Chronic administration of bombesin stimulates antral gastrin cell proliferation in the rat. Gastroenterology 1983; 84: 914-919.